HSL BioTechnologies
HSL is a Bio Pharmaceutical company based in Jamaica for the purpose of producing advanced technology medicinal products (vaccines, monoclonal antibodies, recombinant DNA, mRNA protein therapies) for oncological, neurological and metabolic disease treatments, and for infectious disease prevention, through the use of advanced sterile manufacturing and vial/syringe fill/finish technology.
We maintain a strong commitment to corporate responsibility, and we adhere to the principles of diversity, equity and inclusion in the way we engage clients and employees.
We incorporate Environmental, Social and Governance (ESG) considerations in our approach to business.
We maintain a strong commitment to corporate responsibility, and we adhere to the principles of diversity, equity and inclusion in the way we engage clients and employees.
We incorporate Environmental, Social and Governance (ESG) considerations in our approach to business.
Our Purpose
To build and operate a world class BioPharmaceutical (biologics) manufacturing plant and supply hub (CDMO) of the highest quality and integrity, and establish USFDA and EU approved biologics capability in Jamaica and the Caribbean. This 400,000 square foot biologics manufacturing facility will be the first of its kind in the English-speaking Caribbean
